ANA-negative severe lupus-like presentation: Is it lupus or not?

antinuclear antibody negative (ANA‐negative) epilepsy renal failure systemic lupus erythematosus (SLE)

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 12 07 2023
revised: 07 10 2023
accepted: 16 10 2023
medline: 15 11 2023
pubmed: 15 11 2023
entrez: 15 11 2023
Statut: epublish

Résumé

Systemic lupus erythematosus is difficult to diagnose in patients who are antinuclear antibody (ANA) negative and lack typical clinical manifestations. For such patient who presented ANA-negative severe lupus-like manifestations, the diagnosis and treatment are a huge challenge. Histological findings may provide clues to diagnosis. Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease characterized by formation of autoantibodies to nuclear and cytoplasmic antigens. It was reported that a small subset of patients had typical clinical features of SLE with consistently negative antinuclear antibody (ANA), but such disease is usually mild and rarely involves multisystem. At present, there are no reports about severe lupus with ANA continued negative. Our report describes a 34-year-old Chinese woman who presented renal failure, multiple serous cavity effusion, and epilepsy, without malar rash, photosensitivity, lymphopenia, and arthritis. Further renal biopsy pathology revealed lupus-like nephritis. Autoantibodies, including ANA, antibodies against Smith and against double stranded DNA, were negative. Such a ANA negative and lack of typical clinical symptoms of SLE patient, but with severe lupus-like manifestations, whether it was lupus or not is worth discussing.

Identifiants

pubmed: 37965182
doi: 10.1002/ccr3.8145
pii: CCR38145
pmc: PMC10641295
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e8145

Informations de copyright

© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

The authors have no conflicts of interest.

Références

Clin J Am Soc Nephrol. 2019 Nov 7;14(11):1605-1615
pubmed: 31653670
Ren Fail. 2010;32(9):1025-30
pubmed: 20863204
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Indian J Nephrol. 2020 Sep-Oct;30(5):301-306
pubmed: 33707816
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
J Bras Nefrol. 2021 Oct-Dec;43(4):586-590
pubmed: 33179718
Arthritis Care Res (Hoboken). 2018 Mar;70(3):428-438
pubmed: 28544593
Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902
pubmed: 30044551
Nephrol Dial Transplant. 2017 Apr 1;32(4):654-662
pubmed: 28340077
Rheumatol Int. 2007 Jan;27(3):281-4
pubmed: 16972085
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
N Engl J Med. 2003 Oct 16;349(16):1526-33
pubmed: 14561795
Arthritis Rheum. 1982 Nov;25(11):1271-7
pubmed: 7138600
Pediatr Nephrol. 1999 Oct;13(8):683-7
pubmed: 10502127
Lupus. 2000;9(2):116-9
pubmed: 10787008
Ann Rheum Dis. 2019 Sep;78(9):1151-1159
pubmed: 31383717

Auteurs

Shuangxi Li (S)

Department of Nephrology Changhai Hospital, The Navy Medical University Shanghai China.

Qi Bian (Q)

Department of Nephrology Changhai Hospital, The Navy Medical University Shanghai China.

Classifications MeSH